Clinical Trials List
2017-06-02 - 2020-02-28
Phase III
Terminated3
ICD-10C25
Malignant neoplasm of pancreas
ICD-9157.8
Malignant neoplasm of other specified sites of pancreas
-
Trial Applicant
PPD DEVELOPMENT (HK) LIMITED
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2025/08/20
Investigators and Locations
Co-Principal Investigator
- Yee Chao Division of Hematology & Oncology
- Yi-Ping Hung Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
11 Stop recruiting
Audit
CRO
Co-Principal Investigator
- 蔡文銓 Division of Others
The Actual Total Number of Participants Enrolled
0 Stop recruiting
Co-Principal Investigator
- Chia-Jui Yen Division of Hematology & Oncology
- Nai-Jung Chiang Division of Hematology & Oncology
- 趙盈瑞 Division of General Surgery
- 姜乃榕 Division of Hematology & Oncology
- Li-Tzong Chen Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Stop recruiting
Audit
None
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
15 participants
-
Global
566 participants
